Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Geoffrey S. DowPresident and CEO | 60 Degrees PharmaceuticalsSXTP | Open-market buy | 06/12 | 06/15 | 7,350 sh | $1.38 | $10,143 | +43.8% |
Geoffrey S. DowPresident and CEO | 60 Degrees PharmaceuticalsSXTP | Open-market buy | 25/12/15 | 25/12/16 | 9,670 sh | $0.80 | $7,736 | +19.4% |
60 Degrees PharmaceuticalsSXTP | Open-market buy | 25/12/10–25/12/11 | 25/12/12 | 12,963 sh2 trades | $0.94avg. | $12,206.46 | +35.0% | |
60 Degrees PharmaceuticalsSXTP | Open-market buy | 25/06/03 | 25/06/05 | 5,000 sh2 trades | $2.88avg. | $14,410 | +46.2% | |
60 Degrees PharmaceuticalsSXTP | Open-market buy | 24/12/12–24/12/16 | 24/12/18 | 13,000 sh7 trades | $1.65avg. | $21,400 | +31.6% | |
60 Degrees PharmaceuticalsSXTP | Open-market buy | 24/12/05–24/12/09 | 24/12/09 | 73,951 sh3 trades | $1.21avg. | $89,669.4 | +358.5% | |
60 Degrees PharmaceuticalsSXTP | Open-market buy | 24/11/19–24/11/21 | 24/11/21 | 7,000 sh3 trades | $0.91avg. | $6,355 | +51.4% | |
Cheryl XuDirector | 60 Degrees PharmaceuticalsSXTP | Open-market buy | 24/08/27 | 24/09/11 | 5,000 sh | $1.70 | $8,500 | +13.9% |
Cheryl XuDirector | 60 Degrees PharmaceuticalsSXTP | Open-market buy | 24/01/31 | 24/02/02 | 200,000 sh | $0.38 | $76,000 | +88.9% |
Geoffrey S. DowPresident and CEO | 60 Degrees PharmaceuticalsSXTP | Open-market buy | 24/01/31 | 24/02/02 | 25,974 sh | $0.38 | $9,870.12 | +3.8% |